[Results of 18 months of experimentation with an antipeptic (Ebimar) in duodenal ulcers].
D016282:Aspartic Acid Endopeptidases; D004381:Duodenal Ulcer; D006801:Humans; D010434:Pepsin A / Q000037:antagonists & inhibitors*; D010437:Peptic Ulcer / Q000628:therapy*; D011134:Polysaccharides
D011134:Polysaccharides; C001130:Ebimar; D016282:Aspartic Acid Endopeptidases; D010434:Pepsin A
PEPSINS/antagonists; PEPTIC ULCER/therapy